Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.
Cantore M, Fiorentini G, Luppi G, Rosati G, Caudana R, Piazza E, Comella G, Ceravolo C, Miserocchi L, Mambrini A, Del Freo A, Zamagni D, Aitini E, Marangolo M.
Cantore M, et al. Among authors: del freo a.
J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):51-7.
J Exp Clin Cancer Res. 2003.
PMID: 16767907
Clinical Trial.